Key facts
- This page summarizes Karen L. Daniel's Form 4 filing for Teladoc Health, Inc. (TDOC).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 24 May 2024, 16:26.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Sale
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Additional SEC filing notes
Section 16 status
Karen L. Daniel is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Footnote F1
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Footnote F2
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on September 15, 2023.
Footnote F3
Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
Footnote F4
On May 25, 2023, the reporting person was granted 9,834 restricted stock units, vesting in full on May 22, 2024.